CREDIT SUISSE AG/

Holdings History for Pulmonx Corp - Common Stock, par value $0.001 per share (LUNG)

Symbol: LUNG on Nasdaq
Investment type: Equity / Common Stock, par value $0.001 per share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Option	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Mar 2024		0%	+0%	$446,137	48,127	+2,331	+5.1%	$9.27	Q1 2024
31 Dec 2023		0%	+0%	$583,899	45,796	+1,422	+3.2%	$12.75	Q4 2023
30 Sep 2023		0%	+0%	$458,383	44,374	+8,980	+25%	$10.33	Q3 2023
30 Jun 2023		0%	+0%	$464,016	35,394	+3,916	+12%	$13.11	Q2 2023
31 Mar 2023		0%	+0%	$351,924	31,478	+3,864	+14%	$11.18	Q1 2023
31 Dec 2022		0%	+0%	$232,785	27,614	+6,229	+29%	$8.43	Q4 2022
30 Sep 2022		0%	+0%	$356,000	21,385	+4,356	+26%	$16.65	Q3 2022
30 Jun 2022		0%	+0%	$251,000	17,029	+1,419	+9.1%	$14.74	Q2 2022
30 Jun 2022			0%	$1,000	93	0		$10.75 ^*	Q2 2022
31 Mar 2022			0%	$2,000	65	0		$30.77 ^*	Q1 2022
31 Mar 2022		0%	+0%	$388,000	15,610	+2,728	+21%	$24.86	Q1 2022
31 Dec 2021		0%	+0%	$412,000	12,882	+527	+4.3%	$31.98	Q4 2021
31 Dec 2021			0%	$1,000	24	0		$41.67 ^*	Q4 2021
31 Dec 2021	call		-0%	$0	0	-40,000	-100%	$1.63	Q4 2021
30 Sep 2021		0%	+0%	$445,000	12,355	+1,418	+13%	$36.02	Q3 2021
30 Sep 2021			0%	$1,000	23	0		$43.48 ^*	Q3 2021
30 Sep 2021	call	0%	+0%	$1,439,000	40,000	+40,000	NEW	$35.98	Q3 2021
30 Jun 2021			0%	$1,000	15	0		$66.67 ^*	Q2 2021
30 Jun 2021		0%	+0%	$483,000	10,937	+10,937	NEW	$44.16	Q2 2021
31 Mar 2021			-0%	$0	0	-3,315	-100%	$1.63	Q1 2021
31 Dec 2020		0%	+0%	$229,000	3,315	+3,315	NEW	$69.08	Q4 2020

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.